{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:54:34Z","timestamp":1772582074257,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00787-025-02882-8","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:06:27Z","timestamp":1762160787000},"page":"631-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of methylphenidate and the risk of cardiovascular diseases in children and adolescents with a family history of heart diseases and congenital heart diseases: A self-controlled case series study"],"prefix":"10.1007","volume":"35","author":[{"given":"Min-Jing","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Hsin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2934-5814","authenticated-orcid":false,"given":"Yi-Lung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-4922","authenticated-orcid":false,"given":"Vincent Chin-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2882_CR1","doi-asserted-by":"crossref","unstructured":"Cabral MDI, Liu S, Soares N (2019) Attention-deficit\/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth. Translational Pediatrics:S104-S113","DOI":"10.21037\/tp.2019.09.08"},{"issue":"11","key":"2882_CR2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMra1917069","volume":"383","author":"S Cortese","year":"2020","unstructured":"Cortese S (2020) Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med 383(11):1050\u20131056","journal-title":"N Engl J Med"},{"key":"2882_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00023210-200923000-00004","volume":"23","author":"SB Wigal","year":"2009","unstructured":"Wigal SB (2009) Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs 23:21\u201331","journal-title":"CNS Drugs"},{"key":"2882_CR4","doi-asserted-by":"crossref","unstructured":"Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B (2015) Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primers 1(15020","DOI":"10.1038\/nrdp.2015.20"},{"issue":"3","key":"2882_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bcp.13000","volume":"82","author":"C Renoux","year":"2016","unstructured":"Renoux C, Shin JY, Dell\u2019Aniello S, Fergusson E, Suissa S (2016) Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995\u20132015. Br J Clin Pharmacol 82(3):858\u2013868","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"2882_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","volume":"5","author":"SR Raman","year":"2018","unstructured":"Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad \u00d8, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Potteg\u00e5rd A, Pratt NL, Roughead EE, Saint-Gerons M, St\u00fcrmer D, Su T, Zoega CC, Sturkenbroom H, Chan M, Coghill EW, Ip D, Wong P ICK (2018) Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry 5(10):824\u2013835","journal-title":"Lancet Psychiatry"},{"key":"2882_CR7","doi-asserted-by":"crossref","unstructured":"Storeb\u00f8 OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsb\u00f8l B, Simonsen E, Gluud C (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev 2015(11):Cd009885","DOI":"10.1002\/14651858.CD009885.pub2"},{"issue":"5","key":"2882_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biopsych.2019.04.009","volume":"86","author":"Z Chang","year":"2019","unstructured":"Chang Z, Ghirardi L, Quinn PD, Asherson P, D\u2019Onofrio BM, Larsson H (2019) Risks and benefits of attention-deficit\/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry 86(5):335\u2013343","journal-title":"Biol Psychiatry"},{"issue":"9","key":"2882_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A (2018) Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727\u2013738","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"2882_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/CRD.0000000000000234","volume":"27","author":"TB Fay","year":"2019","unstructured":"Fay TB, Alpert MA (2019) Cardiovascular effects of drugs used to treat Attention-Deficit\/Hyperactivity disorder part 2: impact on cardiovascular events and recommendations for evaluation and monitoring. Cardiol Rev 27(4):173\u2013178","journal-title":"Cardiol Rev"},{"issue":"7","key":"2882_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jacc.2020.05.081","volume":"76","author":"N Torres-Acosta","year":"2020","unstructured":"Torres-Acosta N, O\u2019Keefe JH, O\u2019Keefe CL, Lavie CJ (2020) Cardiovascular effects of ADHD therapies: JACC review topic of the week. J Am Coll Cardiol 76(7):858\u2013866","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2882_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jpeds.2014.05.043","volume":"165","author":"AS Kelly","year":"2014","unstructured":"Kelly AS, Rudser KD, Dengel DR, Kaufman CL, Reiff MI, Norris AL, Metzig AM, Steinberger J (2014) Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants. J Pediatr 165(4):755\u2013759","journal-title":"J Pediatr"},{"issue":"11","key":"2882_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43597","volume":"5","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yao H, Li L, Du Rietz E, Andell P, Garcia-Argibay M, D\u2019Onofrio BM, Cortese S, Larsson H, Chang Z (2022) Risk of cardiovascular diseases associated with medications used in Attention-Deficit\/Hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open 5(11):e2243597","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2882_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2215-0366(23)00042-1","volume":"10","author":"KKC Man","year":"2023","unstructured":"Man KKC, H\u00e4ge A, Banaschewski T, Inglis SK, Buitelaar J, Carucci S, Danckaerts M, Dittmann RW, Falissard B, Garas P, Hollis C, Konrad K, Kovshoff H, Liddle E, McCarthy S, Neubert A, Nagy P, Rosenthal E, Sonuga-Barke EJS, Zuddas A, Wong ICK, Coghill D (2023) Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the attention deficit hyperactivity disorder drugs use chronic effects (ADDUCE) study. Lancet Psychiatry 10(5):323\u2013333","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"2882_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamapsychiatry.2023.4294","volume":"81","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D\u2019Onofrio BM, Brikell I, Kuja-Halkola R, Lichtenstein P, Johnell K, Larsson H, Chang Z (2024) Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiat 81(2):178\u2013187","journal-title":"JAMA Psychiat"},{"key":"2882_CR16","unstructured":"(2019) National Institute for Health and Care Excellence: Guidelines. In: Attention deficit hyperactivity disorder: diagnosis and management. National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2018., London"},{"key":"2882_CR17","doi-asserted-by":"crossref","unstructured":"Wolraich ML, Hagan JF Jr., Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W (2019) Clinical practice guideline for the Diagnosis, Evaluation, and treatment of Attention-Deficit\/Hyperactivity disorder in children and adolescents. Pediatrics 144(4)","DOI":"10.1542\/peds.2019-2528"},{"key":"2882_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC (2019) Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol 11:349\u2013358","journal-title":"Clin Epidemiol"},{"issue":"3","key":"2882_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","volume":"114","author":"CY Hsieh","year":"2015","unstructured":"Hsieh CY, Chen CH, Li CY, Lai ML (2015) Validating the diagnosis of acute ischemic stroke in a National health insurance claims database. J Formos Med Assoc 114(3):254\u2013259","journal-title":"J Formos Med Assoc"},{"key":"2882_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2016.04.069","volume":"215","author":"SF Sung","year":"2016","unstructured":"Sung SF, Hsieh CY, Lin HJ, Chen YW, Yang YH, Li CY (2016) Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database. Int J Cardiol 215:277\u2013282","journal-title":"Int J Cardiol"},{"key":"2882_CR21","doi-asserted-by":"crossref","unstructured":"Farrington P, Whitaker H, Ghebremichael Weldeselassie Y (2018) Self-Controlled case series studies: A modelling guide with R, 1st edn. Chapman and Hall\/CRC","DOI":"10.1201\/9780429491313-1"},{"issue":"1","key":"2882_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40263-019-00686-4","volume":"34","author":"R Houghton","year":"2020","unstructured":"Houghton R, de Vries F, Loss G (2020) Psychostimulants\/Atomoxetine and serious cardiovascular events in children with ADHD or autism spectrum disorder. CNS Drugs 34(1):93\u2013101","journal-title":"CNS Drugs"},{"issue":"2","key":"2882_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jaac.2011.11.008","volume":"51","author":"M Olfson","year":"2012","unstructured":"Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC (2012) Stimulants and cardiovascular events in youth with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 51(2):147\u2013156","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2882_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2550","volume":"353","author":"JY Shin","year":"2016","unstructured":"Shin JY, Roughead EE, Park BJ, Pratt NL (2016) Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ 353:i2550","journal-title":"BMJ"},{"issue":"3","key":"2882_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/wps.21020","volume":"21","author":"L Li","year":"2022","unstructured":"Li L, Chang Z, Sun J, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, Brikell I, Jernberg T, Solmi M, Cortese S, Larsson H (2022) Attention-deficit\/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry 21(3):452\u2013459","journal-title":"World Psychiatry"},{"issue":"10","key":"2882_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/pds.5322","volume":"30","author":"HE Jeong","year":"2021","unstructured":"Jeong HE, Lee H, Lai EC, Liao TC, Man KKC, Wong ICK, Coghill D, Chi MH, Hsieh CY, Shin JY (2021) Association between methylphenidate and risk of myocardial infarction: a multinational self-controlled case series study. Pharmacoepidemiol Drug Saf 30(10):1458\u20131467","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2882_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1542\/peds.2010-3371","volume":"127","author":"H Schelleman","year":"2011","unstructured":"Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S (2011) Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127(6):1102\u20131110","journal-title":"Pediatrics"},{"issue":"1","key":"2882_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00467-005-2051-1","volume":"21","author":"JA Samuels","year":"2006","unstructured":"Samuels JA, Franco K, Wan F, Sorof JM (2006) Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 21(1):92\u201395","journal-title":"Pediatr Nephrol"},{"key":"2882_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4515","volume":"354","author":"I Petersen","year":"2016","unstructured":"Petersen I, Douglas I, Whitaker H (2016) Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ 354:i4515","journal-title":"BMJ"},{"issue":"3","key":"2882_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20(3):236\u2013242","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2882_CR31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2188\/jea.JE20140076","volume":"24","author":"CL Cheng","year":"2014","unstructured":"Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH (2014) Validation of acute myocardial infarction cases in the National health insurance research database in Taiwan. J Epidemiol 24(6):500\u2013507","journal-title":"J Epidemiol"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-025-02882-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:46Z","timestamp":1772578966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-025-02882-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2882"],"URL":"https:\/\/doi.org\/10.1007\/s00787-025-02882-8","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}